母源纺锤体移植治疗特发性不孕夫妇反复体外受精失败的首项初步研究
一项前瞻性初步研究纳入25对反复IVF失败(既往3-11个周期)的特发性不孕夫妇,采用母源纺锤体移植(MST)共28个周期,获6名儿童(19次胚胎移植,7次临床妊娠)。儿童发育无异常,但1名儿童出现线粒体DNA逆转(出生时母源单倍型占30%-60%)。作者认为MST可行性获初步提示,但疗效结论尚早。
要点
- MST后28个周期获6名儿童,19次胚胎移植,7次临床妊娠。
- 5名儿童mtDNA几乎完全(>99%)来自供者,1名出生时母源mtDNA占30%-60%。
- 儿童随访至12-24月龄发育无异常,核DNA均来自双亲。
核心结论
- 本初步研究首次提示MST用于特发性不孕且反复IVF失败患者的可行性,重建卵母细胞可产生能着床、足月发育并产出表面健康新生儿的胚胎。
- 考虑本研究局限性,声称MST对不孕治疗有效为时过早。
- 1名MST后出生儿童检测到mtDNA逆转,该发现可能对线粒体替代疗法有影响。
研究设计与样本
- 前瞻性初步研究,在IVF中心开展。
- 纳入25对不孕夫妇,既往多次IVF失败(范围3-11个周期),无既往妊娠,无mtDNA疾病史。
- 研究聚焦<40岁女性,既往IVF表现为低受精率和/或胚胎发育受损。
- 严重男性因素不孕夫妇不符合条件;卵母细胞供者有既往成功IVF结局,按标准实践与患者匹配。
主要发现
- 28个MST周期产生6名儿童(19次胚胎移植,7次临床妊娠)。
- 儿童儿科随访在出生至12-24月龄间进行,发育无异常。
- DNA指纹确认MST儿童的核DNA遗传自双亲,无卵母细胞供者贡献。
- 5名儿童mtDNA几乎完全(>99%)来自供者;1名儿童囊胚阶段mtDNA携带率低(0.8%),出生时母源mtDNA单倍型增至总量的30%-60%。
局限性
- 作者指出,考虑本研究局限性,声称MST对不孕治疗有效为时过早。
- 1名MST后出生儿童检测到mtDNA逆转,该发现可能对线粒体替代疗法有影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To gain insights into the technical feasibility of maternal spindle transfer (MST) applied in the context of repeated in vitro fertilization (IVF) failures for the treatment of idiopathic infertility. DESIGN: A prospective pilot study. SETTING: IVF center. PATIENT(S): Twenty-five infertile couples with multiple previous unsuccessful IVF cycles (range, 3-11), no previous pregnancy, and no history of mitochondrial DNA (mtDNA) disease participated. The study focused on women <40 years, with previous IVF attempts characterized by a pattern of low fertilization rates and/or impaired embryo development. Couples with severe male-factor infertility were not eligible. Oocyte donors with previous successful IVF outcomes were matched with patients according to standard practice. INTERVENTION(S): We performed MST by transferring metaphase II spindles from the patients' oocytes into the previously enucleated donor oocytes, followed by intracytoplasmic sperm injection, in vitro embryo culture, blastocyst biopsy, and vitrification. Only euploid blastocysts were considered for embryo transfer. MAIN OUTCOME MEASURE(S): Outcome measures included oocyte fertilization, blastocyst development, clinical pregnancy and live birth, incidence of mitochondrial carryover and potential mtDNA reversal, as well as general health of the children born. RESULT(S): Twenty-eight MST cycles produced 6 children (19 embryo transfers, 7 clinical pregnancies). Pediatric follow-up of the children, performed at intervals from birth to 12-24 months of age, revealed their development to be unremarkable. DNA fingerprinting confirmed that the nuclear DNA of MST children was inherited from both parents, without any contribution from the oocyte donor. For 5 of the children, mtDNA was derived almost exclusively (>99%) from the donor. However, 1 child, who had similarly low mtDNA carryover (0.8%) at the blastocyst stage, showed an increase in the maternal mtDNA haplotype, accounting for 30% to 60% of the total at birth. CONCLUSION(S): This pilot study provides the first insights into the feasibility of applying MST for patients with idiopathic infertility and repeated IVF failures. Reconstructed oocytes produced embryos capable of implanting, developing to term and producing apparently healthy newborns/children. However, claims concerning the efficacy of MST with respect to infertility treatment would be premature considering the limitations of this study. Importantly, mtDNA reversal was detected in one child born after MST, a finding with possible implications for mitochondrial replacement therapies. CLINICAL TRIAL REGISTRATION NUMBER: Pilot trial registry number, ISRCTN11455145. The date of registration: 20/02/2018. The date of enrolment of the first patients: 18/03/2018.
引用
- Costa-Borges N, Nikitos E, Späth K, et al. First pilot study of maternal spindle transfer for the treatment of repeated in vitro fertilization failures in couples with idiopathic infertility. Fertil Steril. 2023. PMID: 36787873. doi:10.1016/j.fertnstert.2023.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。